| Recruiting | Zinc as an Adjunctive Therapy for Cervical Dystonia NCT07140874 | University of Florida | Phase 2 |
| Recruiting | Effect of Vibro-tactile Stimulation Intensity on Head Posture in Cervical Dystonia NCT07245615 | University of Minnesota | N/A |
| Recruiting | A Study of IPN10200 for the Treatment of Cervical Dystonia in Adults NCT06937931 | Ipsen | Phase 2 |
| Suspended | Study of the Oral Treatment MTR-601 in Cervical Dystonia NCT06830642 | Motric Bio | Phase 2 |
| Recruiting | Safety and Effectiveness of Valbenazine as Adjunct Therapy to Botulinum Toxin Injections in Cervical Dystonia NCT06771323 | Virginia Commonwealth University | Phase 2 |
| Terminated | Three-dimensional Analysis of Obliquus Capitis Inferior Muscle Function in the Rotatory Form of Cervical Dysto NCT05327985 | Fondation Ophtalmologique Adolphe de Rothschild | — |
| Not Yet Recruiting | Comparison of Pallidal With Subthalamic Deep Brain Stimulation for Cervical Dystonia NCT05715138 | Chinese PLA General Hospital | N/A |
| Completed | Assessment of Long-term Clinical Response to BoNT in Cervical Dystonia NCT05884528 | Merz Therapeutics GmbH | — |
| Completed | Dystonia Treatment With Injections Supplemented By Transcranial Magnetic Stimulation NCT04916444 | University of Florida | N/A |
| Completed | Efficacy and Safety of 10-Week or Shorter vs 12-Week or Longer Injection Intervals of Botulinum Toxin NCT05103202 | University of Texas Southwestern Medical Center | — |
| Completed | Clinical Study of Ingrezza (Valbenazine) for the Treatment of Cervical Dystonia NCT05157100 | The Orthopedic Foundation | Phase 4 |
| Completed | Extension Study of ABP-19000 to Evaluate Safety and Efficacy of Repeat Treatments of ABP-450 in Cervical Dysto NCT04871451 | AEON Biopharma, Inc. | Phase 2 |
| Completed | A Phase 2 Study to Evaluate the Safety and Efficacy of ABP-450 in the Treatment of Cervical Dystonia NCT04849988 | AEON Biopharma, Inc. | Phase 2 |
| Unknown | Long-term Outcome of DBS Versus Botulinum Toxin Treatment in Cervical Dystonia NCT04432285 | Oslo University Hospital | — |
| Unknown | Conversion to Dysport in CD NCT04270214 | Western University, Canada | N/A |
| Completed | Clinical Trial to Compare the Safety and Efficacy of Botulax® Versus Botox® in Patients With Cervical Dystonia NCT04171258 | Hugel | Phase 1 |
| Unknown | Tele-yoga and Dystonia NCT04348669 | Rutgers, The State University of New Jersey | N/A |
| Completed | Abobotulinum Toxin and Neubotulinum Toxin Injection in Cerivical Dystonia NCT03805152 | Department of Medical Services Ministry of Public Health of Thailand | Phase 3 |
| Completed | Relief of Pain in Patients With Cervical Dystonia Through the Use of Transcutaneous Electric Nerve Stimulation NCT04949594 | Central Hospital, Nancy, France | — |
| Unknown | A Trial of Non-invasive Stimulation in Cervical Dystonia NCT04057911 | Western University, Canada | N/A |
| Enrolling By Invitation | Physiotherapy and Botox for Cervical Dystonia: Impact of Sensory Tricks and Brain Imaging Insights NCT06881147 | IRCCS San Raffaele | N/A |
| Completed | Telemedicine Follow-up for Patients With Cervical Dystonia Treated With Neurotoxin Injections NCT03969537 | Vanderbilt University Medical Center | — |
| Completed | Neubotulinum Toxin Injection in Cerivical Dystonia NCT04582929 | Department of Medical Services Ministry of Public Health of Thailand | Phase 3 |
| Completed | Long-Term Safety and Efficacy of Repeat Treatments of DaxibotulinumtoxinA for Injection in Adults With Isolate NCT03617367 | Revance Therapeutics, Inc. | Phase 3 |
| Completed | Single Treatment of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia (ASPEN-1) NCT03608397 | Revance Therapeutics, Inc. | Phase 3 |
| Completed | Non-Motor Features of Cervical Dystonia (CD) NCT03471923 | Vanderbilt University Medical Center | — |
| Completed | Assessment of Brain Activities in Cervical Dystonia NCT02959645 | University of Minnesota | — |
| Completed | Safety and Tolerability of Perampanel in Cervical Dystonia NCT02131467 | University Health Network, Toronto | Phase 1 / Phase 2 |
| Withdrawn | tDCS in Cervical Dystonia NCT02180139 | University of Minnesota | N/A |
| Completed | Neurophysiologic Study of Patient With Essential Tremor and Dystonic Tremor NCT03041714 | National Institute of Neurological Disorders and Stroke (NINDS) | — |
| Completed | Cholinergic Receptor Imaging in Dystonia NCT02689466 | National Institute of Neurological Disorders and Stroke (NINDS) | — |
| Completed | Propensity to Develop Plasticity in the Parieto-Motor Networks in Dystonia From the Perspective of Abnormal Hi NCT02504905 | National Institute of Neurological Disorders and Stroke (NINDS) | EARLY_Phase 1 |
| Completed | A Retrospective Chart Review of BOTOX® and Xeomin® for the Management of Cervical Dystonia and Blepharospasm NCT02245958 | Allergan | — |
| Completed | Novel Stimulation Patterns for the Treatment of Dystonia NCT02468843 | University of Florida | — |
| Completed | Integration of the Cervical Proprioceptive Signals in Patients With Cervical Dystonia NCT02834871 | Fondation Ophtalmologique Adolphe de Rothschild | N/A |
| Completed | Neurotoxin and Physical Therapy NCT02177617 | University of Florida | Phase 4 |
| Completed | Analysis of Three-dimensional Movements of the Head in Cervical Dystonia NCT02069548 | Fondation Ophtalmologique Adolphe de Rothschild | — |
| Completed | Effect of Osteopathic Manipulative Medicine on Motor Function and Quality of Life in Cervical Dystonia NCT02420106 | New York Institute of Technology | N/A |
| Completed | Post-marketing Surveillance of Administration of Botulinum Toxin Type B(NerBloc)-Investigation of the Clinical NCT02175719 | Eisai Co., Ltd. | — |
| Completed | Post-marketing Surveillance of Administration of Botulinum Toxin Type B(NerBloc)-Investigation of the Clinical NCT02175693 | Eisai Co., Ltd. | — |
| Completed | Identification of Optimal Stimulation Site for Cervical Dystonia Symptoms: An Exploratory Study NCT01859247 | University of New Mexico | N/A |
| Completed | Long Term Safety And Effectiveness Of Dysport® In Adults With Cervical Dystonia NCT01753336 | Ipsen | Phase 3 |
| Completed | Efficacy and Safety of MEDITOXIN® in Cervical Dystonia NCT03905304 | Medy-Tox | Phase 3 |
| Completed | A Retrospective Chart Review of BOTOX® and Xeomin® for the Treatment of Cervical Dystonia and Blepharospasm NCT01814774 | Allergan | — |
| Completed | Efficacy and Safety of DYSPORT® Using 2mL Dilution in Adults With Cervical Dystonia. NCT01753310 | Ipsen | Phase 3 |
| Completed | Phase IV-Cervical Dystonia-INTEREST IN CD2 NCT01753349 | Ipsen | — |
| Unknown | The Impact of Botulinum Toxin Treatment in Quality of Life of Cervical Dystonia Patients NCT01664013 | Roongroj Bhidayasiri | Phase 4 |
| Completed | Insights Into Deep Brain Stimulation (DBS) for Cervical Dystonia NCT01671527 | University of Florida | — |
| Completed | Study for Determine the Safety and Efficacy of Clostridium Botulinum Toxin Type A in Subjects With Cervical Dy NCT01588574 | Medy-Tox | Phase 2 |
| Completed | Longitudinal Study for Treatment With Botulinum Toxin A Injections in naïve and Pre-treated Patients Suffering NCT01840462 | Ipsen | — |
| Completed | Open-Label Non-Inferiority Study Evaluating the Efficacy and Safety of Xeomin® in Subjects With Cervical Dysto NCT01486264 | Merz Pharmaceuticals GmbH | Phase 4 |
| Unknown | Clinical and Kinematic Assessment for Determination of Botox® Injection Parameters in Cervical Dystonia NCT02662530 | Western University, Canada | Phase 2 |
| Completed | Study Comparing Short Term Efficacy of Dysport and Dysport NG to Placebo, and to Assess Efficacy and Safety of NCT01261611 | Ipsen | Phase 3 |
| Completed | DYSPORT™ Clinical & Health Economics Outcomes Registry in Cervical Dystonia NCT01314365 | Ipsen | — |
| Completed | Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States NCT01287247 | Merz North America, Inc. | — |
| Completed | Static Graviceptive Functions in Patients With Cervical Dystonia (CD) NCT01180270 | Kirsten Elwischger | — |
| Completed | Effects of Botulinum Toxin in Cervical Dystonia NCT01056861 | Henry Ford Health System | — |
| Completed | A Study to Compare Dysport® and Botox® in the Treatment of Cervical Dystonia NCT00950664 | Seoul National University Hospital | Phase 4 |
| Completed | CD-PROBE: Cervical Dystonia Patient Registry for the Observation of onabotulinumtoxinA Efficacy NCT00836017 | Allergan | — |
| Completed | Botox for Cervical Dystonia Following EMG Mapping NCT00773253 | University of California, San Francisco | Phase 4 |
| Completed | Specialized Physiotherapy Program for Cervical Dystonia NCT00703287 | Dr Donald Grosset | N/A |
| Completed | Study to Evaluate Safety, Efficacy of Botulinum Toxin Type A in Patients With Cervical Dystonia NCT00564681 | Allergan | Phase 2 |
| Completed | Daily Dystonia Practice - A Trial to Investigate NT 201, the Duration of Treatment Effect After One Injection NCT00541905 | Merz Pharmaceuticals GmbH | Phase 4 |
| Unknown | Efficacy of Dronabinol for the Treatment of Cervical Dystonia NCT00418925 | University Health Network, Toronto | Phase 2 |
| Completed | IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Cervical Dystonia NCT00407030 | Merz Pharmaceuticals GmbH | Phase 3 |
| Completed | Plasticity in Cervical Dystonia NCT00323765 | National Institute of Neurological Disorders and Stroke (NINDS) | — |
| Completed | Open-label Extension Study of AbobotulinumtoxinA (Dysport®) for the Treatment of Cervical Dystonia NCT00288509 | Ipsen | Phase 3 |
| Terminated | Keppra for Cervical Dystonia NCT00760318 | University of South Florida | Phase 2 |
| Completed | Randomized, Placebo-Controlled Study of AbobotulinumtoxinA (Dysport®) for the Treatment of Cervical Dystonia NCT00257660 | Ipsen | Phase 3 |
| Completed | Deep Brain Stimulation to Treat Cervical Dystonia NCT00132340 | National Institute of Neurological Disorders and Stroke (NINDS) | Phase 1 |
| Completed | Double-blind, Multicenter Study to Assess the Efficacy of Bilateral Pallidal Stimulation in Patients With Medi NCT00148889 | German Parkinson Study Group (GPS) | Phase 3 |
| Completed | Study to Assess the Efficacy and Safety of Dysport® in Cervical Dystonia NCT00447772 | Ipsen | Phase 3 |
| Completed | Post Marketing Surveillance Study of Dysport NCT00210431 | Ipsen | — |
| Completed | Randomized, Double-Blind, Placebo-Controlled, Parallel, Group Dose-Response, Study of E2014 in Patients WIth S NCT00165776 | Eisai Co., Ltd. | Phase 2 |
| Completed | Botulinum Toxin Type A (Botox) for the Treatment of Cervical Dystonia and Upper Thoracic Muscular Pain NCT00178945 | Vanderbilt University | Phase 1 / Phase 2 |
| Completed | A Multicenter Pilot Study of Pallidal Deep Brain Stimulation for Cervical Dystonia NCT00132990 | University of Calgary | N/A |
| Completed | An Open Label Safety and Immunogenicity Study of MYOBLOC (Neurobloc; Botulinum Toxin Type B) Injectable Soluti NCT00702754 | Solstice Neurosciences | Phase 4 |